Literature DB >> 31487663

Association of plasma lactate concentration at admission of severe preeclampsia to maternal complications.

Anna Peguero1, Rafael Alonso Parra2, Sara Paola Carrillo2, Jose Rojas-Suarez3, Francesc Figueras4.   

Abstract

OBJECTIVE: To evaluate in women with severe preeclampsia the association of lactate concentration at admission with maternal complications.
METHODS: A prospective cohort was created of women with severe preeclampsia consecutively admitted to an Obstetrical High-Dependency Unit. Plasma lactate concentration was measured at admission and its association to maternal complication was evaluated.
RESULTS: A total of 100 women were included, of which 30 (30%) had a maternal complication. The mean lactate plasma concentration in this group was significantly higher than in those uncomplicated cases (2.38 vs 3.1 mmol/L; p < 0.01). A total of 37 (37%) women had lactate concentrations at >3 mmol/L, which was associated to higher incidence of maternal complications (19% vs. 48.6%; p = 0.002; OR 4.03 [95% CI 1.64-9.9]). This association remained independent of other standard severity criteria (OR 3.89; 95%CI 1.22-12.4; p = 0.022).
CONCLUSION: Increased plasma lactate concentrations at admission in women with severe preeclampsia are independently associated to maternal complications.
Copyright © 2019 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Lactate; Preeclampsia

Mesh:

Substances:

Year:  2019        PMID: 31487663     DOI: 10.1016/j.preghy.2019.05.003

Source DB:  PubMed          Journal:  Pregnancy Hypertens        ISSN: 2210-7789            Impact factor:   2.899


  1 in total

1.  Lactic Acid Transport Mediated by Aquaporin-9: Implications on the Pathophysiology of Preeclampsia.

Authors:  Yollyseth Medina; Lucas Acosta; Julieta Reppetti; Ana Corominas; Juanita Bustamante; Natalia Szpilbarg; Alicia E Damiano
Journal:  Front Physiol       Date:  2021-12-02       Impact factor: 4.566

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.